ArticleInternational journal of clinical oncology2025

Treatment-related skin reactions in enfortumab vedotin as a surrogate marker of survival and treatment response.

Jun Nagayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.